Answers are grounded in this paper and cite their sources.
Healthy expansion of white adipose tissue (WAT) depends on efficient adipogenesis to preserve systemic metabolic homeostasis, yet the molecular mechanisms of RNA 3'-end processing that govern adipogenesis remain incompletely characterized. Through integration of human obesity transcriptomes with genome-wide alternative polyadenylation (APA) profiling, we identify CPSF6 (Cleavage and polyadenylation specific factor 6) as a critical regulator of adipocyte differentiation. In vivo conditional deletion of Cpsf6 in adipocyte progenitors results in WAT atrophy and impaired insulin sensitivity under physiological conditions, whereas deletion in mature adipocytes attenuates diet-induced weight gain and restricts adipose tissue expansion, revealing stage-dependent functions of CPSF6 in adipose tissue development and remodeling. Mechanistically, CPSF6 binds the Gsk3b 3'UTR and orchestrates APA-dependent isoform switching, thereby maintaining GSK3β protein abundance. Restoring GSK3β expression in Cpsf6-deficient cells partially rescues impaired adipogenesis. Furthermore, human genetic analyses support a role for CPSF6 in metabolic regulation. These findings reveal a CPSF6-Gsk3b APA axis that coordinates adipogenesis and systemic metabolic homeostasis.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: